Ionis Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $452,049 | $131,612 | $226,576 | $134,000 |
Gross Profit | 447,898 | 130,149 | 222,746 | 132,929 |
EBITDA | 150,233 | -143,891 | -78,873 | -115,914 |
EBIT | 144,779 | -150,930 | -84,140 | -121,407 |
Net Income | 123,551 | -146,938 | -104,349 | -140,480 |
Net Change In Cash | 452,049 | 131,612 | 226,576 | 134,000 |
Free Cash Flow | 137,069 | -163,352 | -141,636 | -124,046 |
Cash | 297,304 | 264,192 | 242,077 | 334,605 |
Basic Shares | 182,331 | 158,735 | 158,000 | 148,593 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $705,138 | $787,647 | $587,000 | $810,000 |
Gross Profit | 693,923 | 778,514 | 573,000 | 799,000 |
EBITDA | -475,081 | -230,010 | -227,758 | -239 |
EBIT | -477,062 | -252,508 | -249,863 | -19,799 |
Net Income | -453,897 | -366,286 | -270,000 | -28,597 |
Net Change In Cash | 705,138 | 787,647 | 587,000 | 810,000 |
Cost of Revenue | -592,301 | 471,527 | ||
Free Cash Flow | -546,227 | -335,524 | -294,469 | 12,898 |
Cash | 242,077 | 399,266 | 276,472 | 2,115,000 |
Basic Shares | 149,514 | 143,190 | 141,848 | 141,021 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | $0.70 |
2025-03-31 | -$0.92 |
2024-12-31 | -$0.43 |
